Machida A, Ohnuma H, Tsuda F, Munekata E, Tanaka T, Akahane Y, Okamoto H, Mishiro S
Department of Immunology, Kitasato Institute, Tokyo, Japan.
Hepatology. 1992 Oct;16(4):886-91. doi: 10.1002/hep.1840160406.
Four distinct genotypes of hepatitis C virus types I, II, III and IV have been identified by comparison of nucleotide sequences of isolates from different areas of the world. We examined the possibility that hepatitis C virus may have serologically definable subtypes. Enzyme-linked immunosorbent assay systems were prepared by use of two synthetic peptides deduced from the putative core protein of hepatitis C virus. The following are the two peptides that were used: (a) IPKARRPEGRTWAQPGY (subtype-1) conserved in hepatitis C virus isolates with type I and type II genotypes; and (b) IPKDRRSTGKSWGKPGY (subtype-2) conserved in type III and type IV genotypes. With the enzyme-linked immunosorbent assays, the subtype-1 antibodies were detected in 26 (68%) of 38 subjects whose hepatitis C virus RNA had been genotyped as type I or type II, whereas subtype-2 antibodies were not detected. Inversely, the subtype-2 antibodies were detected in 10 (56%) of 18 subjects with hepatitis C virus RNA genotypes III or IV, whereas subtype-1 antibodies were detected in none of them. These results suggest that hepatitis C virus has two serologically distinguishable core antigen subtypes, corresponding to either genotype I/II or genotype III/IV. Subtyping of HCV by serological methods would contribute to tracking transmission routes of the virus, especially in cases where serum samples were not stored under conditions to preserve RNA or in infected hosts who have cleared the virus and therefore have only antibodies remaining to identify the infection.
通过比较来自世界不同地区的丙型肝炎病毒分离株的核苷酸序列,已鉴定出四种不同的丙型肝炎病毒基因型,即I型、II型、III型和IV型。我们研究了丙型肝炎病毒可能存在血清学可定义亚型的可能性。利用从丙型肝炎病毒推定的核心蛋白推导的两种合成肽制备了酶联免疫吸附测定系统。以下是所使用的两种肽:(a) IPKARRPEGRTWAQPGY(亚型1),在I型和II型基因型的丙型肝炎病毒分离株中保守;(b) IPKDRRSTGKSWGKPGY(亚型2),在III型和IV型基因型中保守。通过酶联免疫吸附测定,在38名丙型肝炎病毒RNA基因分型为I型或II型的受试者中,有26名(68%)检测到亚型1抗体,而未检测到亚型2抗体。相反,在18名丙型肝炎病毒RNA基因型为III型或IV型的受试者中,有10名(56%)检测到亚型2抗体,而其中无一例检测到亚型1抗体。这些结果表明,丙型肝炎病毒有两种血清学上可区分的核心抗原亚型,分别对应于基因型I/II或基因型III/IV。通过血清学方法对HCV进行亚型分型将有助于追踪病毒的传播途径,特别是在血清样本未在保存RNA的条件下储存的情况下,或在已清除病毒因此仅残留抗体以识别感染的受感染宿主中。